Leukemia Clinical Trials in San Diego

Showing 981-1000 of 1,036 trials

STD Risk Reduction for Heterosexual Methamphetamine Users

NCT00344214

This study will evaluate the effectiveness of a sexual risk reduction intervention in reducing sexual risk behavior in HIV uninfected, heterosexual people who use methamphetamine.

University of California, San Diego432 participantsStarted Oct 2006

San Diego, California, United States

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

NCT00651118

The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone)

Seasonal Allergic Rhinitis

Meda Pharmaceuticals832 participantsStarted Mar 2008

Scottsdale, Arizona, United States • Encinitas, California, United States • Los Angeles, California, United States +40 more locations

STD Risk Reduction for Heterosexual Methamphetamine Users

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Leukemia Trials in Other Cities

Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

Other Conditions in San Diego